AbbVie M21-446: A single arm open-label study to evaluate the efficacy and safety of ABBV-668 in Subjects with Moderate to Severe Ulcerative Colitis

Go Back to All Clinical Trials

AbbVie M21-446: A single arm open-label study to evaluate the efficacy and safety of ABBV-668 in Subjects with Moderate to Severe Ulcerative Colitis

Brief description of study

See protocol

Clinical Study Identifier: s22-01178

ClinicalTrials.gov Identifier: NCT05570006

Principal Investigator: Lev Ginzburg.

Other Investigators: Blanche Fung Liu, Seymour Katz, Robert E Tepper.

Contact the research team to learn more about this study.

Your Email

Not a valid e-mail address

Please Provide Email Address

First Name

First name is mandatory

Last Name

Your Phone

Please provide phone number

Invalid phone number

Valid phone number

Comments

Send Confirmation of This To Me

By clicking "Contact Research Team", your contact information will be sent securely to the research staff associated with the study. You will also receive a copy of this email in your inbox, as well as other notifications to determine your participation status in the study.

Clinical Research Studies